scispace - formally typeset
B

Binu S. Mathew

Researcher at Christian Medical College & Hospital

Publications -  46
Citations -  744

Binu S. Mathew is an academic researcher from Christian Medical College & Hospital. The author has contributed to research in topics: Medicine & Transplantation. The author has an hindex of 12, co-authored 37 publications receiving 466 citations.

Papers
More filters
Journal ArticleDOI

Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy : Second Consensus Report

TL;DR: It is concluded that considerable advances in the different fields of tacrolimus monitoring have been achieved during this last decade, and the Expert Committee concludes that Continued efforts should focus on the opportunities to implement in clinical routine the combination of new standardized PK approaches with PG, and valid biomarkers to further personalize tacolimus therapy and to improve long-term outcomes for treated patients.
Journal ArticleDOI

A limited sampling strategy for tacrolimus in renal transplant patients

TL;DR: The two-point LSS equation can be used as a predictable and accurate measure of AUC(0-12) in stable renal transplant patients prescribed prednisolone and mycophenolate.
Journal ArticleDOI

In vitro study of elution kinetics and bio-activity of meropenem-loaded acrylic bone cement

TL;DR: The use of high-dose meropenem-loaded acrylic bone cement seems to be an attractive option for treatment of resistant Gram-negative orthopaedic infections but needs to be tested in vivo.
Journal ArticleDOI

Cisplatin Concentrations in Long and Short Duration Infusion: Implications for the Optimal Time of Radiation Delivery.

TL;DR: The aim of this study was to determine the total and free cisplatin post infusion concentration changes over time and conclude that radiation should be administered within 30 minutes of completion of the infusion irrespective of the duration of infusion.
Journal ArticleDOI

Posaconazole: an emerging therapeutic option for invasive rhino-orbito-cerebral mucormycosis.

TL;DR: Posaconazole appears to be a safe and effective antifungal agent in diabetic patients with ROCM, especially in those who have toxicity with polyene therapy.